Sermorelin is a growth hormone-releasing hormone (GHRH) analog, often prescribed to stimulate the pituitary gland to produce and release growth hormone. Discontinuing its use generally leads to a gradual return to the individual’s baseline growth hormone production levels, which may have been suboptimal prior to starting the treatment. This contrasts with abruptly ceasing growth hormone therapy itself, where synthetic growth hormone is being supplied directly.
The primary benefit of sermorelin lies in its ability to potentially improve growth hormone secretion, which can affect several physiological processes including muscle growth, fat metabolism, and energy levels. For some individuals, these effects are considered beneficial for overall well-being. However, the long-term effects and sustained benefits after cessation of its use require careful consideration and monitoring.
